Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (811-820 of 850) with videos related to

Pageof 85
Sort By:
Cancers|June 28, 2023
Oncologic Outcomes of Lymph Node Dissection at Salvage Radical ProstatectomyFelix Preisser, Reha-Baris Incesu, Pawel Rajwa, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Journal of Racial and Ethnic Health Disparities|March 23, 2026
Cancer-Specific and Other-Cause Mortality of Asian Pacific Islanders vs. Caucasians Across Eleven Primary CancersNatali Rodriguez Peñaranda, Francesco Di Bello, Andrea Marmiroli, et al.
BMC Cancer|October 14, 2019
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancerSören A Weidemann, Charlotte Sauer, Andreas M Luebke, et al.
European Urology|July 16, 2013
Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision toolLuis A Kluth, Firas Abdollah, Evanguelos Xylinas, et al.
Urologic Oncology|September 29, 2023
Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sitesStefano Tappero, Francesco Barletta, Mattia Luca Piccinelli, et al.
Neoplasia (New York, N.Y.)|August 23, 2017
Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate CancerFrank Jacobsen, Juliane Kraft, Cornelia Schroeder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate CancerGernot Ortner, Xenia Hoderlein, Francesco Barbato, et al.
BJU International|October 10, 2025
Adverse in-hospital outcomes in patients with paraplegia who undergo radical prostatectomyAndrea Marmiroli, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Clinical Genitourinary Cancer|September 10, 2023
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic SitesStefano Tappero, Mattia Luca Piccinelli, Reha-Baris Incesu, et al.
Pageof 85

Showing results (811-820 of 850) with videos related to

Sort By:
Pageof 85
Cancers|June 28, 2023
Oncologic Outcomes of Lymph Node Dissection at Salvage Radical ProstatectomyFelix Preisser, Reha-Baris Incesu, Pawel Rajwa, et al.
Molecular Medicine (Cambridge, Mass.)|March 8, 2020
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusionChristoph Fraune, Luisa Harms, Franziska Büscheck, et al.
Journal of Racial and Ethnic Health Disparities|March 23, 2026
Cancer-Specific and Other-Cause Mortality of Asian Pacific Islanders vs. Caucasians Across Eleven Primary CancersNatali Rodriguez Peñaranda, Francesco Di Bello, Andrea Marmiroli, et al.
BMC Cancer|October 14, 2019
High-level expression of protein tyrosine phosphatase non-receptor 12 is a strong and independent predictor of poor prognosis in prostate cancerSören A Weidemann, Charlotte Sauer, Andreas M Luebke, et al.
European Urology|July 16, 2013
Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision toolLuis A Kluth, Firas Abdollah, Evanguelos Xylinas, et al.
Urologic Oncology|September 29, 2023
Survival of patients with clear cell renal carcinoma according to number and location of organ-specific metastatic sitesStefano Tappero, Francesco Barletta, Mattia Luca Piccinelli, et al.
Neoplasia (New York, N.Y.)|August 23, 2017
Up-regulation of Biglycan is Associated with Poor Prognosis and PTEN Deletion in Patients with Prostate CancerFrank Jacobsen, Juliane Kraft, Cornelia Schroeder, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 6, 2025
The Pelvic Rosetta Classification Project: An Interdisciplinary Proposal for a Lymph Node Map of the Pelvis in Prostate CancerGernot Ortner, Xenia Hoderlein, Francesco Barbato, et al.
BJU International|October 10, 2025
Adverse in-hospital outcomes in patients with paraplegia who undergo radical prostatectomyAndrea Marmiroli, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Clinical Genitourinary Cancer|September 10, 2023
Overall Survival of Metastatic Prostate Cancer Patients According to Location of Visceral Metastatic SitesStefano Tappero, Mattia Luca Piccinelli, Reha-Baris Incesu, et al.
Pageof 85